Prestalia

Active Ingredient(s): Perindopril Arginine + Amlodipine Besylate
FDA Approved: * January 21, 2015
Pharm Company: * SYMPLMED PHARMS LLC
Category: Blood Pressure

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Prestalia Overview

Perindopril is a long-acting ACE inhibitor used to treat high blood pressure, heart failure, or stable coronary artery disease[1] in form of perindopril arginine (trade names include Coversyl, Coversum) or perindopril erbumine (Aceon). According to the Australian government's Pharmaceutical Benefits Scheme website, based on data provided to the Australian Department of Health and Aging by the manufacturer, perindopril arginine and perindopril erbumine are therapeutically equiv...

Read more Prestalia Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Perindopril

Recent Prestalia Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Perindopril Arginine + Amlodipine Besylate
  • Tablet: 10mg + 14mg, 2.5mg + 3.5mg, 3.5mg + 2.5mg, 5mg + 7mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Prestalia: (3 results)

Sorted by National Drug Code
  • 61894-010 Prestalia Oral Tablet by Symplmed Pharmaceuticals, LLC
  • 61894-011 Prestalia Oral Tablet by Symplmed Pharmaceuticals, LLC
  • 61894-012 Prestalia Oral Tablet by Symplmed Pharmaceuticals, LLC

Drugs with one or more similar ingredients: (5 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA